Most pharmaceutical companies are sitting on the patent cliff and their drug pipelines are facing severe exhaustion. The...
Singapore: Cancer is the biggest cause of mortality worldwide as the killer disease claimed an estimated 8.2 million liv...
Singapore: Celltrion Healthcare has announced the launch of Remisma (infliximab) in 12 European markets, namely, Austria...
Blockbusters and super profits. Will the bioscience industry in this decade see these words come to life? More important...
A majority of life science firms are standing on the edge of the patent cliff and their drug pipelines are experiencing ...
Singapore: Korea Health Industry Development Institute (KHIDI) has signed a memorandum of agreement (MoA) for healthcare...
Singapore: Biologics World Korea, which attracted over 130 biologics industry leaders in 2012, has decided to conduct th...
Singapore: WCCT Global announced a mutual cooperation and business agreement with Korea Drug Development Fund (KDDF) lo...
Asia needs a solution, that goes beyond traditional structure, models and pathways, to meet the essential vaccine supply...
Singapore: ViroMed, a leading biotechnology company, announced the final enrollment and administration of 105 patients f...
Singapore: Singapore's Agency for Science, Technology and Research (A*STAR) and Korean Health Industry Development Insti...
The rising demand for cost containment in healthcare and the need to improve quality of services are driving the growth ...
Singapore: Measles in North Korea has turned to be a deadly outbreak in seven years killing three children last week. Th...
Singapore: Boehringer Ingelheim has reported that in Asian populations, Pradaxa (dabigatran etexilate) offers considerab...
Singapore: International pharma companies are concerned about the low pricing of their drugs in the Korean markets and h...
Singapore: Bio and Medical Korea 2014 an international event of the medical industry, was held over three days beginning...
Singapore: Korean scientists have developed a breakthrough technology that can more efficiently and safely reprogram adu...
Singapore: Korea-based Dong-A Pharmaceutical has appointed Mr Lee Dong Hun as its new co-chief executive officer. He wou...
